Versant Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$574K Sell
2,418
-1,050
-30% -$218K 0.05% 242
2026
Q1
$733K Buy
3,468
+1,019
+42% +$219K 0.07% 180
2025
Q4
$503K Buy
2,449
+186
+8% +$35K 0.06% 221
2025
Q3
$355K Hold
2,263
0.05% 311
2025
Q2
$380K Buy
2,263
+54
+2% +$8.01K 0.06% 248
2025
Q1
$304K Hold
2,209
0.05% 286
2024
Q4
$261K Sell
2,209
-403
-15% -$47K 0.06% 148
2024
Q3
$289K Sell
2,612
-160
-6% -$16.7K 0.07% 122
2024
Q2
$273K Buy
2,772
+750
+37% +$76.4K 0.07% 113
2024
Q1
$226K Hold
2,022
0.06% 120
2023
Q4
$204K Hold
2,022
0.06% 129
2023
Q3
$176K Hold
2,022
0.06% 135
2023
Q2
$191K Buy
2,022
+24
+1% +$2.03K 0.06% 131
2023
Q1
$151K Buy
1,998
+1,925
+2,637% +$145K 0.05% 140
2022
Q4
$5.61K Hold
73
﹤0.01% 853
2022
Q3
$5K Hold
73
﹤0.01% 827
2022
Q2
$4K Hold
73
﹤0.01% 895
2022
Q1
$4K Buy
73
+4
+6% +$214 ﹤0.01% 927
2021
Q4
$4K Hold
69
﹤0.01% 940
2021
Q3
$3K Hold
69
﹤0.01% 1017
2021
Q2
$4K Sell
69
-441
-86% -$25.8K ﹤0.01% 952
2021
Q1
$31K Hold
510
0.01% 416
2020
Q4
$27K Hold
510
0.01% 408
2020
Q3
$23K Hold
510
0.01% 382
2020
Q2
$26K Hold
510
0.01% 347
2020
Q1
$24K Hold
510
0.01% 315
2019
Q4
$25K Hold
510
0.01% 390
2019
Q3
$24K Hold
510
0.01% 393
2019
Q2
$24K Sell
510
-175
-26% -$8.07K 0.01% 404
2019
Q1
$32K Sell
685
-12
-2% -$601 0.01% 404
2018
Q4
$31K Hold
697
0.01% 367
2018
Q3
$37K Hold
697
0.02% 386
2018
Q2
$34K Hold
697
0.01% 412
2018
Q1
$43K Buy
697
+7
+1% +$480 0.02% 341
2017
Q4
$42K Hold
690
0.02% 361
2017
Q3
$46K Sell
690
-26
-4% -$1.84K 0.03% 279
2017
Q2
$55K Sell
716
-42
-6% -$3.17K 0.03% 229
2017
Q1
$61K Hold
758
0.03% 216
2016
Q4
$54K Sell
758
-5
-0.7% -$361 0.03% 255
2016
Q3
$59K Sell
763
-16
-2% -$1.29K 0.03% 216
2016
Q2
$60K Hold
779
0.04% 201
2016
Q1
$63K Buy
779
+18
+2% +$1.46K 0.04% 185
2015
Q4
$67K Buy
+761
New +$64.6K 0.04% 175

Other funds holding CAH

Versant Capital Management's CAH Position: Q2 2026 in Review

Versant Capital Management reduced its Cardinal Health (CAH) stake by 30% in Q2 2026, selling an estimated $218K and leaving 2,418 shares worth $574K. The position accounts for 0.05% of the portfolio, ranked #242.

Versant Capital Management first reported a position in CAH in Q4 2015 and has held it in 43 quarters since. The position peaked at $733K in Q1 2026. 229 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Versant Capital Management held 2,418 shares of Cardinal Health worth $574K as of Q2 2026.
  • Versant Capital Management sold 1,050 Cardinal Health shares in Q2 2026, an estimated $218K.
  • Cardinal Health made up 0.05% of Versant Capital Management's portfolio in Q2 2026, its #242 holding.
  • Versant Capital Management first reported a position in Cardinal Health in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Cardinal Health position peaked at $733K in Q1 2026.
  • 229 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.